Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
The combination of cabozantinib (anti-c-MET) with durvalumab (anti-PD-L1) can inhibit tumor angiogenesis and modulate the immune microenvironment, demonstrating promising efficacy in MSS CRC patients refractory to chemotherapy [157]
Page 280 and 281: Lemonick MD, "In our streams: Proza Page 282 and 283: Leveque C, Hougard JM, Resh V, Stat Page 284 and 285: Li X-Z and Nikaido H
2.10 Statistical analysis Data are expressed as mean standard deviation (SD)
Stretch marks are superficial tears in the skin
US$ 22.35
US$ 27.16
US$ 29.39
US$ 24.92
US$ 26.40
US$ 26.86
US$ 21.66
US$ 28.19
US$ 26.06
